magic mushrooms

Australian physicians can prescribe doses of MDMA, aka ecstasy, for PTSD. Psilocybin, the psychoactive ingredient in psychedelic mushrooms, can be given to people with hard-to-treat depression.

The market for gummies, powders and capsules containing extracts of the fungus is raising eyebrows, though, amid concerns from the FDA and in the absence of human clinical trials.

A group of former pro athletes traveled to Jamaica to try psychedelics as a way to help cope with the aftereffects of concussions and a career of body-pounding injuries. Will this still largely untested treatment work?

Hundreds of people have invested thousands of dollars apiece in this budding industry, and some worry that the rollout is proceeding too slowly.

The ballot measure decriminalizes psychedelic mushrooms for those 21 and older and creates state-regulated “healing centers” where participants can experience the drug under the supervision of a licensed “facilitator.”

The effects were modest and waned over time but they occurred with a single experimental dose in people who previously had gotten little relief from standard antidepressants.

A new course at Florida International explores the history of psychedelics and a new frontier for how these substances might have a positive effect on mental illness.

As efforts grow to decriminalize psilocybin, advocates in Washington state are pushing to make magic mushrooms available to dying patients even sooner using Right to Try laws.